Overview

Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

Status:
Completed

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy of tattoo removal using topical imiquimod, 5% cream in conjunction with the 1064nm Nd:YAG laser. This procedure for tattoo removal will be compared to a laser removal alone.

Phase:

Phase 1

Details

Lead Sponsor:

University of Miami

Collaborator:

Graceway Pharmaceuticals, LLC

Treatments:

Imiquimod